Key information

🔎 Fund Overview

RegenETP, Inc. operates as a translational regenerative medicine company. The Company develops functionally polarized human tissues to improve clinical medicine and biomedical research. PolarityTE (formerly Majesco Entertainment) has put the games away to focus on regenerative medicine and tissue engineering. Formerly a video game developer, Majesco acquired the intellectual property of PolarityTE in early 2017 and began developing technology that could allow it to regenerate the body's skin, bone, muscle, cartilage, fat, nerves, and blood vessels. Its first product, SkinTE, is in development as the first platform to regenerate skin in the case of burn. If successful, PolarityTE hopes to expand into other markets, including the acute wound, scar, and hair revision markets. Other technologies in development include OsteoTE (bone), AngioTE (vascular tissue), MyoTE (muscle), CartTE (cartilage), NeuralTE (nerves), and AdiposeTE (fat).